Stem Cell Therapy Market Global Forecast 2025-2030: Breakthroughs in Gene Editing & Cell Therapy Propel Stem Cell Market Expansion to 2030
March 18, 2025 10:43 ET
|
Research and Markets
Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "Stem Cell Therapy Market by Therapy Type (Allogeneic Therapy, Autologous Therapy), Cell Source (Adult Stem Cells, Embryonic Stem Cells, Induced...
Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s Disease
March 11, 2025 08:30 ET
|
Longeveron
Longeveron positive Phase 2 clinical trial data in Alzheimer's disease published in peer reviewed journal Nature Medicine.
Animal Stem Cell Therapy Presents a $338.7 Million Market Opportunity by 2030, Despite Safety and Efficacy Challenges
March 07, 2025 07:35 ET
|
Research and Markets
Dublin, March 07, 2025 (GLOBE NEWSWIRE) -- The "Animal Stem Cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
Longeveron® to Present at the 37th Annual Roth Conference
March 05, 2025 09:25 ET
|
Longeveron
Longeveron to present at the Roth investor conference taking place March 17-18, 2025. Company fireside chat Tuesday, March 18th at 9:00am PT.
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update
February 28, 2025 16:04 ET
|
Longeveron
Longeveron announces 2024 financial results and provides business update. Pivotal Phase 2b clinical trial achieves 90% enrollment.
Longeveron® to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025
February 21, 2025 08:30 ET
|
Longeveron
Longeveron to report full-year 2024 financial results and provide a business update on Friday, February 28, 2025 after the U.S. financial markets close.
Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™
February 18, 2025 09:25 ET
|
Longeveron
WHO approved generic name laromestrocel for stem cell therapy Lomecel-B, being developed as potential treatment for Alzheimer's disease and HLHS.
Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025
February 14, 2025 09:05 ET
|
Longeveron
Longeveron to present at the Emerging Growth Virtual Conference taking place February 18-19, 2025.
Cell Therapy Market Size is Projected to Reach USD 33.93 Billion by 2033, Growing at a CAGR of 22.12%: Straits Research
January 27, 2025 09:09 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The therapeutic use of cells to address medical issues or illnesses is known as cell therapy. Cells or tissues are transplanted into a...
Cell Therapy Market Outlook 2034: Rapid Growth Projected with a 20.8% CAGR, Set to Reach US$ 44.6 Billion, Latest Report by TMR
January 21, 2025 09:35 ET
|
Transparency Market Research
Wilmington, Delaware, Transparency Market Research Inc. –, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The cell therapy market is rapidly evolving, driven by groundbreaking advancements in medical research...